Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Use of vitamin D drops leading to kidney failure in a 54-year-old man

Bourne L. Auguste, Carmen Avila-Casado and Joanne M. Bargman
CMAJ April 08, 2019 191 (14) E390-E394; DOI: https://doi.org/10.1503/cmaj.180465
Bourne L. Auguste
Division of Nephrology (Auguste, Bargman), University of Toronto; Department of Pathology (Avila-Casado), Toronto General Hospital, University Health Network, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmen Avila-Casado
Division of Nephrology (Auguste, Bargman), University of Toronto; Department of Pathology (Avila-Casado), Toronto General Hospital, University Health Network, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanne M. Bargman
Division of Nephrology (Auguste, Bargman), University of Toronto; Department of Pathology (Avila-Casado), Toronto General Hospital, University Health Network, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure 1:
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1:

    Photomicrograph of the tubulointerstitium of a 54-year-old man with vitamin D toxicity showing microcalcifications (arrow). Arterioles display hyalinosis (hematoxylin–eosin stain × 40).

  • Figure 2:
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2:

    Serial 25-hydroxyvitamin D3 (25-OH D), 1,25 dihydroxyvitamin D3 (1,25 OH D) and ionized calcium levels over a 10-month period. Ionized calcium and 1,25 dihydroxyvitamin D3 levels continued to rise 4 weeks after cessation of supplements. Hydroxychloroquine was started at the June clinic visit, and 1,25 dihydroxyvitamin D3 levels steadily decreased after its initiation.

  • Figure 3:
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3:

    Simplified pathway of vitamin D metabolism with a suggested approach to manage hypervitaminosis D. Key steps include the following: Limit sun exposure; Stop oral vitamin D supplements; Use medications such as corticosteroids, ketoconazole and hydroxychloroquine to block 1α-hydroxylase activity; Stop oral calcium supplements to reduce burden of hypercalcemia from hypervitaminosis D. Key enzymes involved in metabolism pathway are shown in green.5–7,11,12

    Image courtesy of Bottle credit: Creativology; Pills credit: BSGStudio

Tables

  • Figures
    • View popup
    Box 1: Relevant serum laboratory values across the patient’s initial and most recent clinic visits over a 10-month period, with hydroxychloroquine started after his second clinic visit*
    Laboratory testVisit no. 1Visit no. 2Visit no. 4Visit no. 5Visit no. 8Visit no. 9Normal range
    Ionized calcium, mmol/L†1.481.541.631.471.261.271.12–1.32
    Calcium, mmol/L‡3.043.213.282.872.572.572.20–2.62
    Phosphate, mmol/L0.950.941.050.890.780.730.80–1.40
    PTH, ng/L4.722.833.7710.37––12.26–71.67
    1,25 dihydroxyvitamin D3, pmol/L§27431323418712510260–206
    25-hydroxyvitamin D3, nmol/L§2411861521359610825–200
    Creatinine, μmol/L37224127123719918664–110
    Estimated GFR, mL/min/1.73m2< 152522263234 >60
    • Note: GFR = glomerular filtration rate, PTH = parathyroid hormone.

    • * The patient’s third clinic visit was a routine visit to check his response to the hydroxychloroquine. Clinic visits occurred every 4–6 weeks.

    • ↵† Corrected for pH 7.4.

    • ↵‡ Corrected for albumin.

    • ↵§ These results became available 2 weeks after blood was drawn on a clinic visit.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 191 (14)
CMAJ
Vol. 191, Issue 14
8 Apr 2019
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Use of vitamin D drops leading to kidney failure in a 54-year-old man
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Use of vitamin D drops leading to kidney failure in a 54-year-old man
Bourne L. Auguste, Carmen Avila-Casado, Joanne M. Bargman
CMAJ Apr 2019, 191 (14) E390-E394; DOI: 10.1503/cmaj.180465

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Use of vitamin D drops leading to kidney failure in a 54-year-old man
Bourne L. Auguste, Carmen Avila-Casado, Joanne M. Bargman
CMAJ Apr 2019, 191 (14) E390-E394; DOI: 10.1503/cmaj.180465
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Discussion
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • Hypercalcemia and a “no observed adverse effect level” intake of vitamin D
  • Misconception about the cause of vitamin D toxicity
  • PubMed
  • Google Scholar

Cited By...

  • Misconception about the cause of vitamin D toxicity
  • Hypercalcemia and a "no observed adverse effect level" intake of vitamin D
  • The authors respond to "Misconception about the cause of vitamin D toxicity"
  • Google Scholar

More in this TOC Section

  • Periorbital petechiae after emesis in a young woman
  • Gastroparesis
  • Oral ivermectin treatment for an infant with crusted scabies
Show more Practice

Similar Articles

Collections

  • Article Types
    • Cases
  • Topics
    • Nephrology
    • Pharmacology & toxicology

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire